Annual Long Term Debt
$42.88 M
-$997.00 K-2.27%
December 31, 2023
Summary
- As of March 12, 2025, GLUE annual long term debt is $42.88 million, with the most recent change of -$997.00 thousand (-2.27%) on December 31, 2023.
- GLUE annual long term debt is now -2.27% below its all-time high of $43.87 million, reached on December 31, 2022.
Performance
GLUE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$40.05 M
-$833.00 K-2.04%
September 30, 2024
Summary
- As of March 12, 2025, GLUE quarterly long term debt is $40.05 million, with the most recent change of -$833.00 thousand (-2.04%) on September 30, 2024.
- Over the past year, GLUE quarterly long term debt has dropped by -$1.78 million (-4.27%).
- GLUE quarterly long term debt is now -13.11% below its all-time high of $46.09 million, reached on June 30, 2022.
Performance
GLUE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
GLUE Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | -4.3% |
| 3 y3 years | - | -8.7% |
| 5 y5 years | - | -8.7% |
GLUE Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.3% | -100.0% | -13.1% | -100.0% |
| 5 y | 5-year | -2.3% | -100.0% | -13.1% | -100.0% |
| alltime | all time | -2.3% | -100.0% | -13.1% | -100.0% |
Monte Rosa Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.05 M(-2.0%) |
| Jun 2024 | - | $40.88 M(-2.3%) |
| Mar 2024 | - | $41.84 M(-2.4%) |
| Dec 2023 | $42.88 M | $42.88 M(-1.5%) |
| Sep 2023 | - | $43.52 M(-1.9%) |
| Jun 2023 | - | $44.37 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $43.27 M(-1.4%) |
| Dec 2022 | $43.87 M(>+9900.0%) | $43.87 M(+3.0%) |
| Sep 2022 | - | $42.59 M(-7.6%) |
| Jun 2022 | - | $46.09 M(+744.7%) |
| Mar 2022 | - | $5.46 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Monte Rosa Therapeutics annual long term debt?
- What is the all time high annual long term debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual long term debt year-on-year change?
- What is Monte Rosa Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly long term debt year-on-year change?
What is Monte Rosa Therapeutics annual long term debt?
The current annual long term debt of GLUE is $42.88 M
What is the all time high annual long term debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual long term debt is $43.87 M
What is Monte Rosa Therapeutics annual long term debt year-on-year change?
Over the past year, GLUE annual long term debt has changed by -$997.00 K (-2.27%)
What is Monte Rosa Therapeutics quarterly long term debt?
The current quarterly long term debt of GLUE is $40.05 M
What is the all time high quarterly long term debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly long term debt is $46.09 M
What is Monte Rosa Therapeutics quarterly long term debt year-on-year change?
Over the past year, GLUE quarterly long term debt has changed by -$1.78 M (-4.27%)